Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a ...

Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug developers backed by its third fund. The Paris-based investment firm closed on the ...

Septerna is joining biotech's IPO on-deck circle, preparing for a public offering with two other startups that have recently ...

Senators may be back in their districts gearing up for next month's elections, but that isn't stopping them from questioning ...

The Centers for Medicare & Medicaid Services wants earlier and more flexible communication with drugmakers during the next ...

BioNTech became a big name in biopharma thanks to its Pfizer-partnered Covid-19 vaccine. It's betting that artificial ...

A Louisiana judge on Monday defended a new state law that keeps drugmakers from imposing certain restrictions around the ...

Gilead announced Wednesday that it will allow certain drug manufacturers to make and sell a generic version of its ...

The European Medicines Agency is looking to speed up its drug review timelines, following a recent report showing how ...

Johnson & Johnson is earmarking over $2 billion to build a new biologics manufacturing facility in Wilson, NC, for a variety ...

After an already brutal year for its Medicare Advantage business, major health insurer Humana said it’s taken a hit to its ...

Teladoc's chief operating officer has resigned due to an executive reshuffle, a few months after the company named a new CEO.